Clinical evaluation of Org NC 45

Area of Science:

• Anesthesiology
• Pharmacology

Background:

• Non-depolarizing neuromuscular blocking drugs are essential for facilitating endotracheal intubation and surgical procedures.
• Evaluating novel agents for improved safety and efficacy profiles is crucial in anesthesia practice.

Purpose of the Study:

• To assess the efficacy and safety of Org NC 45, a new non-depolarizing neuromuscular blocking drug, in adult patients undergoing general anesthesia.
• To determine optimal dosing, duration of action, and antagonism characteristics of Org NC 45.

Main Methods:

• A clinical trial involving 200 adult patients.
• Administration of Org NC 45 at varying doses (0.1, 0.15, 0.2 mg kg-1).
• Evaluation of intubation success, duration of clinical relaxation, effects of repeated doses, and antagonism with neostigmine.

Main Results:

• Satisfactory intubation conditions were achieved in 90% of patients around 90 seconds post-administration.
• Clinical relaxation duration ranged from 23 to 71 minutes, depending on dose and anesthetic technique.
• Repeated doses showed consistent relaxation durations (17-20 min), indicating no cumulation.
• Antagonism of neuromuscular block was prompt and effective with neostigmine.
• No significant cardiovascular effects were observed during routine monitoring.

Conclusions:

• Org NC 45 is an effective non-depolarizing neuromuscular blocking agent with a predictable dose-response relationship.
• The drug provides rapid intubating conditions and manageable duration of action.
• Org NC 45 demonstrates a favorable safety profile with no significant cardiovascular impact and easy reversal.